Background
Stereotactic radiosurgery (SRS) is a highly targeted form of radiotherapy used to treat brain metastases (cancer that has spread to the brain from elsewhere in the body). It can be an important treatment option, but decisions about when and how SRS is used can be complex, particularly when balancing treatment benefits, potential side effects and quality of life.
There is currently variation in how SRS is accessed and delivered across the UK. The Tessa Jowell Brain Cancer Mission and British Radiosurgery Society (BRSS) are working together to develop national expert consensus recommendations to help improve consistency in SRS practice, covering areas such as referral, access, treatment eligibility, delivery and safety.
As this work progresses, brainstrust is bringing together people affected by brain metastases to ensure that patient and caregiver experiences and priorities help shape the developing recommendations.
Our discussion will take place between two rounds of expert consultation, providing an opportunity to explore where clinicians agree, where uncertainty remains and whether anything important from a patient or family perspective has been overlooked.
Who can get involved?
We are looking for:
- People living with brain metastases who have previously received stereotactic radiosurgery (SRS).
- People living with brain metastases who are currently being considered for SRS.
- People living with brain metastases who have been assessed or considered for SRS but have not received it.
- Caregivers, family members and loved ones of someone who has received or been considered for SRS for brain metastases
What will you do?
Join brainstrust for a small, relaxed online conversation exploring your experiences of stereotactic radiosurgery (SRS) for brain metastases.
We’ll share some of the emerging findings from the first round of expert consultation and explore how these reflect your own experiences, concerns and priorities.
We’ll be interested in hearing about your experiences of accessing SRS, making treatment decisions, the information and support you received, and what matters most to you before, during and after treatment.
There are no right or wrong answers, and you don’t need any specialist knowledge. We’re interested in your experiences and perspectives, including anything you feel could be better understood or improved in SRS care.
Why is it important to be part of this conversation?
Your contributions will help researchers consider whether the emerging expert recommendations reflect what matters to patients and families, and whether any important issues have been overlooked.
Importantly, this discussion will take place between the first and second rounds of the expert consensus process, meaning your input can help shape the statements that clinicians will consider during the next round, rather than simply commenting on recommendations once they have been developed.
Your experiences will also help demonstrate why greater consistency in SRS care matters to people affected by brain metastases and support the communication of the final recommendations.
Please note that this workshop will take place online via Zoom. You’ll receive joining details after registering.
